Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Erdal

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Pharmacoepidemiology and Drug Safety|January 22, 2011
Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort studyJonas Bjerring Olesen, Peter Riis Hansen, Steen Zabell Abildstrøm, et al.
Epilepsia|August 27, 2010
Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora diseaseGaetan Lesca, Nadia Boutry-Kryza, Bertrand de Toffol, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Pharmacoepidemiology and Drug Safety|January 22, 2011
Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort studyJonas Bjerring Olesen, Peter Riis Hansen, Steen Zabell Abildstrøm, et al.
Epilepsia|August 27, 2010
Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora diseaseGaetan Lesca, Nadia Boutry-Kryza, Bertrand de Toffol, et al.
Pageof 2